about
Self-efficacy and health-related quality of life in family carers of people with dementia: a systematic review.Acceptance checklist for clinical effectiveness pilot trials: a systematic approachBarriers to social participation among lonely older adults: the influence of social fears and identity.Peer support for family carers of people with dementia, alone or in combination with group reminiscence in a factorial design: study protocol for a randomised controlled trial.The experience of family carers attending a joint reminiscence group with people with dementia: A thematic analysisCognitive behavioural therapy (CBT) for anxiety in people with dementia: study protocol for a randomised controlled trial.Befriending carers of people with dementia: randomised controlled trial.Involving service users in the development of the Support at Home: Interventions to Enhance Life in Dementia Carer Supporter Programme for family carers of people with dementia.Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trialReview: befriending modestly reduces depressive symptoms in varied populations.Donepezil slows decline in daily life activities in people with moderate to severe Alzheimer's disease and alleviates caregiver burden.Measuring family caregiver efficacy for managing behavioral and psychological symptoms in dementia: a psychometric evaluation.Cognitive behavior therapy for anxiety in people with dementia: a clinician guideline for a person-centered approach.Factors influencing the person-carer relationship in people with anxiety and dementia.Cognitive-behavioural therapy for anxiety in dementia: pilot randomised controlled trial.Does befriending by trained lay workers improve psychological well-being and quality of life for carers of people with dementia, and at what cost? A randomised controlled trial.Mental health of carers.Carers Assessment of Difficulties Index (CADI): psychometric properties for use with carers of people with dementia.Comments on donepezil open label trial.Reviewing psychosocial interventions for family carers of people with dementiaBefriending carers of people with dementia: a cost utility analysis4 thematic patterns described the experience of placing a relative with Alzheimer's disease in a special care unitCognitive behavioural therapy reduces psychological distress in carers of people with Parkinson's diseaseThe perceived challenge of everyday technologies in Sweden, the United States and England: Exploring differential item functioning in the everyday technology use questionnaireEmbedding patient and public involvement: Managing tacit and explicit expectationsFacilitators and barriers to co-research by people with dementia and academic researchers: Findings from a qualitative studyThe nature of decision-making in people living with dementia: a systematic reviewRelational experiences of people seeking help and assessment for subjective cognitive concern and memory lossPerceived risks, concession travel pass access and everyday technology use for out-of-home participation: cross-sectional interviews among older people in the UK
P50
Q34319243-D5814A22-5D6B-46A7-9930-98170C9108E1Q34768562-65298ECD-35EB-413D-9B63-3FD7BE49562EQ35112901-064828CF-3B30-4CF0-A15C-A86C58274122Q35233101-8607FE89-3D8E-451B-8B1A-13E7AA3EA1E4Q36263776-0F0B26CD-B2E0-4C1B-85D7-90A5538395C7Q36389811-ACC26EEB-3688-481E-92BD-31C6C5963B28Q36700730-37D08D68-0578-4E95-9D05-07E14F5E0110Q36700730-E91D5030-1115-4293-8931-69AF3E736FE6Q37333203-941E6851-A7DE-4262-BBC3-166E01320310Q37399169-E6095D40-D9B3-4A2C-9332-548DE7272FD4Q37777549-934F1A46-5FA6-4A36-86BF-BA23968240D5Q44760361-739F6779-34F0-4646-82AE-4EDC5426E71AQ45382146-59339B78-1A2A-4EC3-824F-ECD5C15061B2Q47771611-20F8A2CC-54DE-47EF-88FB-BBC8AE0D491DQ48077550-0D7A5271-54AE-4BCB-B65E-EEDC0981FA22Q48111727-D98E6126-B939-4E87-A730-ECF1C4D50026Q50135440-C0A2EF2A-5516-4288-9D67-E798E4FB9621Q51920622-C4B22729-58B9-4EEC-B382-127BDD6D6342Q53021428-0BC1B159-8227-478D-857B-6F52B874996AQ53923569-E8C9266F-0C75-4F93-9CC6-6C720305F314Q58103799-38370078-24CF-4B47-84F6-8F78E005805AQ59391938-06704B58-D22C-4E05-B617-AC3FD88108C4Q74614515-6CCFCE55-815E-4155-99DB-C26841A9F931Q81397772-20865073-C41C-4523-92E9-846F2D603246Q90159643-E68CDF31-50DB-4611-B8A6-5A516ED2B1D0Q90187387-4A44E4E9-E429-4022-B9D9-01F28FCEC0F5Q90222420-70EF8A57-30D8-4C6F-8FE1-C063D021BB29Q90305352-D90B74A7-E401-42DC-A858-902F1D9B42D2Q92655489-F6EC2EFF-E9C3-403A-A7E6-A03B56F87977Q96169363-3AF55B9E-DA68-49D0-A559-12663F54F055
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Georgina Charlesworth
@ast
Georgina Charlesworth
@en
Georgina Charlesworth
@es
Georgina Charlesworth
@nl
type
label
Georgina Charlesworth
@ast
Georgina Charlesworth
@en
Georgina Charlesworth
@es
Georgina Charlesworth
@nl
prefLabel
Georgina Charlesworth
@ast
Georgina Charlesworth
@en
Georgina Charlesworth
@es
Georgina Charlesworth
@nl
P106
P31
P496
0000-0002-5278-1756